Similar Articles
3211 Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil: A pilot study
3212 Survivin expression in early hepatocellular carcinoma and post-treatment with anti-cancer drug under hypoxic culture condition
3213 Effects of a 24-week course of interferon-α therapy after curative treatment of hepatitis C virus-associated hepatocellular carcinoma
3214 Type 2 dıabetes mellıtus and CA 19-9 levels
3215 Hepatic steatosis as a possible risk factor for the development of hepatocellular carcinoma after eradication of hepatitis C virus with antiviral therapy in patients with chronic hepatitis C
3216 Low-dose intermittent interferon-alpha therapy for HCV-related liver cirrhosis after curative treatment of hepatocellular carcinoma
3217 Early steroid withdrawal after liver transplantation for hepatocellular carcinoma
3218 Acute pancreatitis and cholangitis: A complication caused by a migrated gastrostomy tube
3219 Portal vein thrombosis: Etiology and clinical outcome of cirrhosis and malignancy-related non-cirrhotic, non-tumoral extrahepatic portal venous obstruction
3220 Upper gastrointestinal bleeding from duodenal vascular ectasia in a patient with cirrhosis
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA